Seaport Therapeutics, Inc. (NASDAQ: SPTX) reported Q3 EPS of ($0.49), $0.49 worse than the analyst estimate of $0.00.

For earnings history and earnings-related data on Seaport Therapeutics, Inc. (SPTX) click here.